Skip to main content

Sulfasalazine Enteric-Coated and Immediate-Release Tablets Shortage

Last Updated: March 21, 2025
Status: Current

Products Affected - Description
    • Sulfasalazine tablet, Teva, 500 mg, bottle, 500 count, NDC 00093-3234-05
    • Sulfasalazine tablet, Teva, 500 mg, bottle, 1000 count, NDC 00093-3234-10
Reason for the Shortage
    • Viatris has sulfasalazine available.
    • Teva did not provide a reason for the shortage.
    • Pfizer has Azulfidine and Azulfidine Entabs available.
Available Products
    • Azulfidine Entabs coated tablet, Pfizer, 500 mg, bottle, 100 count, NDC 00013-0102-50
    • Azulfidine Entabs coated tablet, Pfizer, 500 mg, bottle, 300 count, NDC 00013-0102-60
    • Sulfasalazine coated tablet, Greenstone (Viatris), 500 mg, bottle, 100 count, NDC 59762-0104-05
    • Sulfasalazine coated tablet, Greenstone (Viatris), 500 mg, bottle, 300 count, NDC 59762-0104-06
    • Azulfidine tablet, Pfizer, 500 mg, bottle, 100 count, NDC 00013-0101-10
    • Azulfidine tablet, Pfizer, 500 mg, bottle, 300 count, NDC 00013-0101-30
    • Sulfasalazine tablet, Greenstone (Viatris), 500 mg, bottle, 100 count, NDC 59762-5000-05
    • Sulfasalazine tablet, Greenstone (Viatris), 500 mg, bottle, 300 count, NDC 59762-5000-06
    • Sulfasalazine tablet, Teva, 500 mg, bottle, 100 count, NDC 00093-3234-01

Estimated Resupply Dates

    • Teva has sulfasalazine immediate-release 500 mg tablets in 500 count and 1,000 count bottles on intermittent back order and the company is releasing product as it becomes available.

Updated

Updated March 21, 2025 by Leslie Jensen, PharmD, Drug Information Specialist. Created January 8, 2020 by Rachael Freeman, PharmD, BCPS. © 2025, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer